Temporary increase in costs due to preparations for transferring production processes to the new factory in Vietnam
First written in FY2017-Q3. 3 of 6 entries say "Materialised", first in FY2017. Latest entry: FY2019-Q3.
No other company in this theme has enough history to compare yet.
- FY2019-Q3MitigatedAnnual report
「As production of Ales needles following the start-up of the Phu Yen No. 2 plant gained traction, among other factors, segment profit (operating profit) was ¥1,784 million, up 4.1% year on year.」
The disclosure states that, after the temporary burden associated with transferring processes to and commencing operations at the new plant, production gained momentum and profit increased. - FY2019-Q1MitigatedAnnual report
「In addition to the increase in net sales, increased production of Ailes needles at the new plant in Vietnam gained momentum, among other factors. As a result, segment profit (operating profit) was ¥634 million, up 67.7% year on year.」
The disclosure states that, whereas temporary increases in costs and expenses associated with transferring processes to and commencing operations at the new plant had affected profit in the past, production gained momentum and segment profit increased 67.7%. - FY2018-Q2MaterialisedAnnual report
「Although net sales increased, expenses rose as production processes were transferred to the new plant and operations commenced there. As a result, segment profit (operating profit) was ¥1,017 million, up 16.2% year on year.」
The increase in expenses associated with transferring processes to and commencing operations at the new plant continues to be reflected in actual results as a factor affecting segment profit for Ailes needle-related products. - FY2018-Q1MaterialisedAnnual report
「Segment profit (operating profit) was ¥378 million, up 4.3% year on year, mainly because expenses increased in connection with the transfer of production processes to and the start-up of the new Vietnam plant, among other factors.」
The increase in expenses associated with transferring processes to and commencing operations at the new plant actually continued to affect segment profit for Ailes needle-related products this quarter. - FY2017MaterialisedAnnual report
「Although net sales increased, segment profit (operating profit) was ¥1,577 million, down 8.7% year on year, mainly because expenses increased in connection with the transfer of production processes to the new Vietnam plant and the start-up of the new plant, among other factors.」
The increase in expenses associated with transferring processes to and starting operations at the new plant again emerged this fiscal year as a decline in segment profit for eyeless needle-related products. - FY2017-Q3First statedAnnual report
「Costs temporarily increased in preparation for transferring production processes to the new Vietnam plant, while selling, general and administrative expenses also increased, among other factors.」
The company states that the temporary cost increase associated with preparations to transfer production processes to the new Vietnam plant actually occurred as a factor behind the decline in profit from eyeless needle-related products.